Biosimilar Contract Manufacturing Market to be dominated by Recombinant Non-Glycosylated Proteins Type through 2028
Increasing chronic disease is expected to drive the growth of global biosimilar contract manufacturing in the forecast period, 2024-2028. According to TechSci Research report, “ Biosimilar Contract Manufacturing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F ”, the global biosimilar contract manufacturing market is anticipated to grow at an impressive rate in the forecast period, 2024-2028. This can be ascribed to the increasing prevalence of diabetes, various type of cancers, neurological disorders, and availability of biosimilar at lower costs over branded products across the globe. Additionally, increasing focus on contract developments in countries like China, India and increasing prevalence of auto immune diseases are expected to create lucrative opportunities for the market growth in coming years. Besides, increasing research and development activities in biotechnology industry is further expected to support the market growth. Sim...